Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104512759 | 10451275 | 9 | F | 2014 | 20160915 | 20140912 | 20160922 | PER | US-PFIZER INC-2014253630 | PFIZER | 65.00 | YR | F | Y | 121.50000 | KG | 20160922 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104512759 | 10451275 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75MG X 3 (225MG), Q A.M. | D | H79672 | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||
104512759 | 10451275 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 225 MG, 1X/DAY | D | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
104512759 | 10451275 | 3 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 20 MG, 1X/DAY [NIGHTLY] | 0 | 20 | MG | QD | |||||||
104512759 | 10451275 | 4 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | |||||||
104512759 | 10451275 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
104512759 | 10451275 | 6 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
104512759 | 10451275 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | 100 UNITS, 1X/DAY (NIGHTLY) | A5903 | 0 | 100 | IU | QD | |||||||
104512759 | 10451275 | 8 | C | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY | M90071 | 0 | 50 | MG | TABLET | TID | |||||
104512759 | 10451275 | 9 | C | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY | 0 | 50 | MG | TABLET | TID | ||||||
104512759 | 10451275 | 10 | C | LYRICA | PREGABALIN | 1 | 0 | TABLET | |||||||||||
104512759 | 10451275 | 11 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, 1X/DAY AT NIGHT | 0 | 50 | MG | QD | |||||||
104512759 | 10451275 | 12 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | QD | |||||||
104512759 | 10451275 | 13 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | UNK | 0 | ||||||||||
104512759 | 10451275 | 14 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | Oral | 600 MG, 2X/DAY | 0 | 600 | MG | BID | |||||||
104512759 | 10451275 | 15 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | ||||||||
104512759 | 10451275 | 16 | C | APIDRA | INSULIN GLULISINE | 1 | USUALLY 4 OR 5 UNITS, UNK | 0 | |||||||||||
104512759 | 10451275 | 17 | C | APIDRA | INSULIN GLULISINE | 1 | (4-10 UNIT ), DAILY | 0 | |||||||||||
104512759 | 10451275 | 18 | C | ASPIRIN. | ASPIRIN | 1 | UNK, DAILY | 0 | |||||||||||
104512759 | 10451275 | 19 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 650 MG, AS NEEDED (TAKE 2 TABLETS BY MOUTH EVERY 4 (FOUR) HOURS) | 0 | 650 | MG | TABLET | |||||||
104512759 | 10451275 | 20 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG, DAILY | 0 | 500 | MG | TABLET | |||||||
104512759 | 10451275 | 21 | C | ASPIRIN 81 | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | TABLET | |||||||
104512759 | 10451275 | 22 | C | CALCIUM + VITAMIN D | CALCIUMVITAMIN D | 1 | Oral | 1 DF, 2X/DAY (CALCIUM: 600, VIT D: 200) | 0 | 1 | DF | TABLET | BID | ||||||
104512759 | 10451275 | 23 | C | CINNAMON. | CINNAMON | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | ||||||||
104512759 | 10451275 | 24 | C | COQ10 | UBIDECARENONE | 1 | Oral | 50 MG, DAILY | 0 | 50 | MG | ||||||||
104512759 | 10451275 | 25 | C | MOTRIN | IBUPROFEN | 1 | Oral | 800 MG, AS NEEDED (EVERY A (SIX) HOURS ) | 0 | 800 | MG | TABLET | |||||||
104512759 | 10451275 | 26 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
104512759 | 10451275 | 27 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD | ||||||
104512759 | 10451275 | 28 | C | MEVACOR | LOVASTATIN | 1 | Oral | 20 MG, 1X/DAY (NIGHTLY) | 0 | 20 | MG | TABLET | QD | ||||||
104512759 | 10451275 | 29 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, 2X/DAY (WITH MEAL) | 0 | 1000 | MG | TABLET | BID | ||||||
104512759 | 10451275 | 30 | C | DESYREL | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, AS NEEDED (AT BEDTIME) | 0 | 50 | MG | TABLET | |||||||
104512759 | 10451275 | 31 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 500 MG 2 EVERY A.M | 0 | 1000 | MG | QD | ||||||||
104512759 | 10451275 | 32 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, 2X/DAY | 0 | 1000 | MG | BID | ||||||||
104512759 | 10451275 | 33 | C | MULTIVITE | VITAMINS | 1 | UNK UNK, DAILY | 0 | |||||||||||
104512759 | 10451275 | 34 | C | GLUCOSAMINE/CHONDROITIN | 2 | 2 B.I.D | 0 | BID | |||||||||||
104512759 | 10451275 | 35 | C | SITAGLIPTIN | SITAGLIPTIN | 1 | 0 | ||||||||||||
104512759 | 10451275 | 36 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104512759 | 10451275 | 1 | Depression |
104512759 | 10451275 | 3 | Hypercholesterolaemia |
104512759 | 10451275 | 4 | Diabetes mellitus |
104512759 | 10451275 | 5 | Type 2 diabetes mellitus |
104512759 | 10451275 | 7 | Diabetes mellitus |
104512759 | 10451275 | 8 | Neuropathy peripheral |
104512759 | 10451275 | 9 | Back pain |
104512759 | 10451275 | 10 | Neuralgia |
104512759 | 10451275 | 11 | Sleep disorder |
104512759 | 10451275 | 12 | Hypertension |
104512759 | 10451275 | 14 | Hypertriglyceridaemia |
104512759 | 10451275 | 15 | Sinus disorder |
104512759 | 10451275 | 16 | Diabetes mellitus |
104512759 | 10451275 | 19 | Pain |
104512759 | 10451275 | 25 | Pain |
104512759 | 10451275 | 28 | Blood cholesterol increased |
104512759 | 10451275 | 30 | Sleep disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104512759 | 10451275 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104512759 | 10451275 | Depressed mood | |
104512759 | 10451275 | Depression | |
104512759 | 10451275 | Drug withdrawal syndrome | |
104512759 | 10451275 | Dysphonia | |
104512759 | 10451275 | Fatigue | |
104512759 | 10451275 | Headache | |
104512759 | 10451275 | Irritability | |
104512759 | 10451275 | Nervousness | |
104512759 | 10451275 | Pruritus | |
104512759 | 10451275 | Sleep disorder | |
104512759 | 10451275 | Suicidal ideation | |
104512759 | 10451275 | Tearfulness | |
104512759 | 10451275 | Tinnitus | |
104512759 | 10451275 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104512759 | 10451275 | 1 | 2000 | 0 | ||
104512759 | 10451275 | 2 | 2001 | 201409 | 0 | |
104512759 | 10451275 | 3 | 2012 | 0 | ||
104512759 | 10451275 | 4 | 2012 | 0 | ||
104512759 | 10451275 | 5 | 2013 | 0 | ||
104512759 | 10451275 | 7 | 2005 | 0 | ||
104512759 | 10451275 | 8 | 2015 | 0 | ||
104512759 | 10451275 | 11 | 2008 | 0 | ||
104512759 | 10451275 | 12 | 2011 | 0 | ||
104512759 | 10451275 | 13 | 2012 | 0 | ||
104512759 | 10451275 | 14 | 2015 | 0 | ||
104512759 | 10451275 | 15 | 2008 | 0 | ||
104512759 | 10451275 | 16 | 201604 | 0 | ||
104512759 | 10451275 | 18 | 2010 | 0 |